Press Releases | Medtronic

Month Year

Email alerts

Mar 31, 2014

Medtronic CoreValve® System Demonstrates Long-Term Durability

Final Follow-up of CoreValve CE Pivotal Study Shows Sustained Valve Function

MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...
Mar 30, 2014

Medtronic Wins European Patent Office Ruling

MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent...
Mar 30, 2014

Medtronic Global SYMPLICITY Registry Shows Strong Safety Profile of the Symplicity(TM) Renal Denervation System

Six-Month Analysis of First 1,000 Patients Enrolled in Real-World Patient Registry Presented at ACC.14

MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...
Mar 30, 2014

World's First Transcatheter Valve, Medtronic Melody® Transcatheter Pulmonary Valve Shows Positive Clinical Outcomes in Real-World Study

Has Repaired Hearts of 6,000+ Patients; More Than Half Are Children

MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...
Mar 29, 2014

Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial

CoreValve High Risk Study: FDA Determines Expert Panel Not Required

MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...
Mar 29, 2014

Medtronic Releases Results of SYMPLICITY HTN-3

Medtronic Commits to Further Clinical Investigation and Determining Path Forward for Next U.S. IDE with FDA

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...
Mar 28, 2014

AORN Foundation, Covidien Team to Offer New Tools for Emerging Nurse Leaders

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...
Mar 27, 2014

First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries

Study Will Assess Defibrillator Therapy in Patients Most At-Risk for SCA

Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...
Mar 25, 2014

Study Published in JAMA Shows Covidien Endoscopic Ablation Therapy Effective In Treating Barrett’s Esophagus

DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...
Mar 19, 2014

Covidien Declares Quarterly Cash Dividend

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

Show per page